title: MYD88 (L265P) mutation is associated with an unfavourable outcome of primary central nervous system lymphoma.
authors.affiliation: Department of Clinical and Experimental Haematology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan.
authors.forename: Keiichiro
authors.initials: K
authors.lastname: Hattori
authors.affiliation: Department of Clinical and Experimental Haematology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan.
authors.forename: Mamiko
authors.initials: M
authors.lastname: Sakata-Yanagimoto
authors.affiliation: Ibaraki Clinical Education and Training Centre, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan.|Department of Haematology, Ibaraki Prefectural Central Hospital, Tsukuba, Ibaraki, Japan.
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Okoshi
authors.affiliation: School of Medicine, University of Tsukuba, Tsukuba, Japan.
authors.forename: Yuki
authors.initials: Y
authors.lastname: Goshima
authors.affiliation: Division for Health Service Promotion, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
authors.forename: Shintaro
authors.initials: S
authors.lastname: Yanagimoto
authors.affiliation: Department of Clinical and Experimental Haematology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan.
authors.forename: Rie
authors.initials: R
authors.lastname: Nakamoto-Matsubara
authors.affiliation: Department of Pathology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan.
authors.forename: Taiki
authors.initials: T
authors.lastname: Sato
authors.affiliation: Department of Pathology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan.
authors.forename: Masayuki
authors.initials: M
authors.lastname: Noguchi
authors.affiliation: Department of Neurosurgery, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan.
authors.forename: Shingo
authors.initials: S
authors.lastname: Takano
authors.affiliation: Department of Neurosurgery, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan.
authors.forename: Eichi
authors.initials: E
authors.lastname: Ishikawa
authors.affiliation: Department of Neurosurgery, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan.
authors.forename: Tetsuya
authors.initials: T
authors.lastname: Yamamoto
authors.affiliation: Department of Neurosurgery, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan.
authors.forename: Akira
authors.initials: A
authors.lastname: Matsumura
authors.affiliation: Department of Clinical and Experimental Haematology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan.
authors.forename: Shigeru
authors.initials: S
authors.lastname: Chiba
mesh_terms: D014408:Biomarkers, Tumor; D016543:Central Nervous System Neoplasms / Q000235:genetics* / Q000401:mortality* / Q000628:therapy; D006801:Humans; D008223:Lymphoma / Q000235:genetics* / Q000401:mortality* / Q000628:therapy; D009154:Mutation; D053594:Myeloid Differentiation Factor 88 / Q000235:genetics*; D011379:Prognosis; D016016:Proportional Hazards Models; D012307:Risk Factors
chemical_list: D014408:Biomarkers, Tumor; C507779:MYD88 protein, human; D053594:Myeloid Differentiation Factor 88
keywords: MYD88 mutation; clinical sequencing; primary central nervous system lymphoma; targeted sequencing